You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft-versus-host-disease prophylaxis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Suzhou (Sitagliptin + Standard

Recruiting
  • Acute-graft-versus-host Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sitagliptin + Standard Prophylaxis
  • Standard Prophylaxis
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jan 13, 2022

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Graft Vs Host Disease Trial in United States (PRO 140)

Terminated
  • Graft Vs Host Disease
  • PRO 140
  • Miami, Florida
  • +7 more
Jan 13, 2022

Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

Terminated
  • Hematologic Malignancies
  • Aurora, Colorado
  • +16 more
Apr 29, 2022

GVHD Trial in Morgantown, Milwaukee (Atorvastatin calcium)

Completed
  • Graft vs Host Disease
  • Atorvastatin calcium
  • Morgantown, West Virginia
  • +1 more
Sep 9, 2021

GVHD, Hematopoietic Cell Transplantation Recipient Trial in New Brunswick (Dietary Intervention, Laboratory Biomarker Analysis)

Terminated
  • Graft Versus Host Disease
  • Hematopoietic Cell Transplantation Recipient
  • Dietary Intervention
  • Laboratory Biomarker Analysis
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Graft-versus-Host Disease Trial in Cologne (Everolimus)

Completed
  • Graft-versus-Host Disease
  • Cologne, Germany
    University of Cologne
Mar 16, 2021

Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

Recruiting
  • Acute Leukemia
  • +2 more
  • Darlinghurst, New South Wales, Australia
  • +8 more
Aug 30, 2021

GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)

Active, not recruiting
  • Graft-Versus-Host Disease
  • Hematological Malignancies
  • Antwerpen,, Antwerpen, Belgium
  • +12 more
Mar 22, 2022

Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Atlanta, Georgia
    Northside Hospital
Sep 21, 2023

Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Jun 8, 2022

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Fecal Microbiota Transplantation Capsule
  • Placebo
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 6, 2023

Leukemia, GVHD, ATG, Transplantation Trial in Beijing (anti thymoglobulin)

Completed
  • Leukemia, GVHD, ATG, Transplantation
  • anti thymoglobulin
  • Beijing, Beijing, China
    Peking university people's hospital
Sep 23, 2020

Patients at Risk for Chronic Graft-Versus-Host Disease

Not yet recruiting
  • cGVHD
  • Non-Interventional
  • (no location specified)
Jun 16, 2023

Chronic GVHD Trial in United States (drug, procedure, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Tampa, Florida
  • +4 more
Aug 10, 2023

Acute Graft Versus Host Disease

Not yet recruiting
  • GVHD,Acute
  • blood sample
  • Detroit, Michigan
    Henry Ford Health System
Jan 30, 2023

Acute GVHD Trial (Itolizumab, Methylprednisolone)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Apr 10, 2023

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem

Completed
  • Leukemia, Acute Lymphoblastic
  • +2 more
  • Allogeneic stem cell transplantation
  • +3 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Nov 19, 2020

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • OrcaGraft (Orca-Q)
  • Duarte, California
  • +7 more
Oct 28, 2021

Intestinal GVHD Trial in Seattle (procedure, biological, dietary supplement, other)

Not yet recruiting
  • Intestinal Graft Versus Host Disease
  • Colonoscopy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 25, 2023

Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • Allogeneic Stem Cell Transplant
  • App
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023